1. Home
  2. LEGH vs CTNM Comparison

LEGH vs CTNM Comparison

Compare LEGH & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Legacy Housing Corporation (TX)

LEGH

Legacy Housing Corporation (TX)

HOLD

Current Price

$27.68

Market Cap

620.7M

ML Signal

HOLD

Logo Contineum Therapeutics Inc.

CTNM

Contineum Therapeutics Inc.

HOLD

Current Price

$16.07

Market Cap

550.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEGH
CTNM
Founded
2005
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
620.7M
550.7M
IPO Year
2018
2024

Fundamental Metrics

Financial Performance
Metric
LEGH
CTNM
Price
$27.68
$16.07
Analyst Decision
Buy
Buy
Analyst Count
3
4
Target Price
$25.00
$19.00
AVG Volume (30 Days)
73.1K
534.7K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
0.46
EPS
1.44
N/A
Revenue
$164,567,000.00
N/A
Revenue This Year
$11.90
N/A
Revenue Next Year
$6.58
N/A
P/E Ratio
$19.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.29
$8.60
52 Week High
$31.34
$17.79

Technical Indicators

Market Signals
Indicator
LEGH
CTNM
Relative Strength Index (RSI) 46.11 51.38
Support Level $25.03 $13.65
Resistance Level $30.92 $16.86
Average True Range (ATR) 0.85 0.94
MACD -0.18 -0.05
Stochastic Oscillator 8.28 49.92

Price Performance

Historical Comparison
LEGH
CTNM

About LEGH Legacy Housing Corporation (TX)

Legacy Housing Corp builds, sells, and finances manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores, and are also sold directly to manufactured home communities. The Company manufactures and provides for the transport of manufactured homes, provides wholesale financing to dealers and mobile home parks, provides retail financing to consumers, and is involved in financing and developing new manufactured home communities. The Company manufactures its mobile homes at plants in Fort Worth, Texas; Commerce, Texas; and Eatonton, Georgia. The Company also sells homes directly to consumers, through its own retail stores, and to dealers and mobile home parks.

About CTNM Contineum Therapeutics Inc.

Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds targeting challenging molecular pathways and has built a portfolio of small molecule drug candidates. Its pipeline includes drug candidates in clinical development, such as PIPE-791, an LPA1 receptor antagonist being studied for idiopathic pulmonary fibrosis and chronic pain, and PIPE-307, an M1 receptor inhibitor being evaluated for relapsing-remitting multiple sclerosis and other depressive disorders.

Share on Social Networks: